Myriad Genetics, Inc. - Common Stock (NQ:MYGN)
3.865
+0.045
(+1.18%)
Streaming Delayed Price
Updated: 3:18 PM EDT, May 26, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 624,704 |
| Open | 3.830 |
| Bid (Size) | 3.860 (3,200) |
| Ask (Size) | 3.870 (1,900) |
| Prev. Close | 3.820 |
| Today's Range | 3.720 - 3.880 |
| 52wk Range | 3.530 - 8.590 |
| Shares Outstanding | 93,500,000 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
3 Small-Cap Stocks We Think Twice About
April 24, 2026
1 Cash-Burning Stock to Target This Week and 2 We Question
April 13, 2026
3 Healthcare Stocks with Open Questions
April 02, 2026
3 Reasons to Sell MYGN and 1 Stock to Buy Instead
March 11, 2026
Frequently Asked Questions
Is Myriad Genetics, Inc. - Common Stock publicly traded?
Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
What exchange does Myriad Genetics, Inc. - Common Stock trade on?
Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
What is the current price of Myriad Genetics, Inc. - Common Stock?
The current price of Myriad Genetics, Inc. - Common Stock is 3.865
When was Myriad Genetics, Inc. - Common Stock last traded?
The last trade of Myriad Genetics, Inc. - Common Stock was at 05/26/26 03:18 PM ET
What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
The market capitalization of Myriad Genetics, Inc. - Common Stock is 361.38M
How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
Myriad Genetics, Inc. - Common Stock has 361M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube